Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study

Dexamethasone provides benefits in patients with coronavirus disease 2019 (COVID-19), although data regarding immunological profiles and viral clearance are limited. This study aimed to evaluate for differences in biomarkers among patients with severe COVID-19 who did and did not receive dexamethaso...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Won-Young, Kweon, Oh Joo, Cha, Min Jae, Baek, Moon Seong, Choi, Seong-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253399/
https://www.ncbi.nlm.nih.gov/pubmed/34214123
http://dx.doi.org/10.1371/journal.pone.0254167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253399/
https://www.ncbi.nlm.nih.gov/pubmed/34214123
http://dx.doi.org/10.1371/journal.pone.0254167

Ejemplares similares